Journal article icon

Journal article : Review

Nicotine receptor partial agonists for smoking cessation

Abstract:

Background

Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract withdrawal symptoms (acting as an agonist) and reducing smoking satisfaction (acting as an antagonist). This is an update of a Cochrane Review first published in 2007.

Objectives

To assess the effectiveness of nicotine receptor partial agonists, including varenicline and cytisine, for smokin... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1002/14651858.CD006103.pub8

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
ORCID:
0000-0002-3757-5591
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
ORCID:
0000-0002-9928-8934
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
ORCID:
0000-0002-0910-0441
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
ORCID:
0000-0002-8942-2167
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Oxford college:
Christ Church
Role:
Author
ORCID:
0000-0003-1919-5189


Publisher:
Cochrane Collaboration
Journal:
Cochrane Database of Systematic Reviews More from this journal
Volume:
23
Issue:
5
Article number:
CD006103
Place of publication:
England
Publication date:
2023-05-05
DOI:
EISSN:
1469-493X


Language:
English
Keywords:
Subtype:
Review
Pubs id:
1340179
Local pid:
pubs:1340179
Deposit date:
2023-05-09

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP